Sherif Gabriel, Ph.D.
About Sherif Gabriel, Ph.D.
Sherif Gabriel, Ph.D., serves as the Senior Vice President and Head of Research and Development at Asklepios BioPharmaceutical, Inc. He has extensive experience in the biopharmaceutical field, having previously held leadership roles at AskBio and H.C. Wainwright & Co.
Current Role at Asklepios BioPharmaceutical
Sherif Gabriel, Ph.D., serves as the Senior Vice President and Head of Research and Development at Asklepios BioPharmaceutical, Inc. (AskBio). He has held this position since 2023, contributing to the organization's strategic direction and research initiatives in the Raleigh-Durham-Chapel Hill area. His leadership is focused on advancing innovative therapies and overseeing the development of new research projects.
Previous Experience at Asklepios BioPharmaceutical
Prior to his current role, Sherif Gabriel worked at Asklepios BioPharmaceutical, Inc. as Vice President of Research and Development from 2021 to 2024. During this three-year tenure, he played a significant role in managing research operations and driving the development of therapeutic solutions within the company.
Experience at H.C. Wainwright & Co.
Sherif Gabriel served as Vice President of Equity Research at H.C. Wainwright & Co., LLC from 2017 to 2019. In this role, he was involved in analyzing market trends and providing insights on biotechnology investments, contributing to the firm's research capabilities.
Education and Academic Background
Sherif Gabriel earned a Doctor of Philosophy (Ph.D.) in Biochemistry and Molecular Biology from the University of Saskatchewan. His academic background provides a strong foundation for his work in research and development within the biopharmaceutical industry.